Hyperion DeFi (NASDAQ:HYPD) Upgraded by Zacks Research to Hold Rating

Hyperion DeFi (NASDAQ:HYPD) was upgraded by analysts at Zacks Research to a “hold” rating in a research report issued on Monday,Zacks.com reports.

A number of other analysts have also issued reports on HYPD. Cantor Fitzgerald assumed coverage on Hyperion DeFi in a report on Tuesday, December 16th. They issued an “overweight” rating and a $4.00 price target for the company. Chardan Capital set a $7.75 target price on Hyperion DeFi and gave the stock a “buy” rating in a report on Wednesday, December 24th. Weiss Ratings reissued a “sell (d-)” rating on shares of Hyperion DeFi in a research report on Wednesday, October 8th. Finally, Wall Street Zen upgraded Hyperion DeFi from a “sell” rating to a “hold” rating in a research note on Saturday, November 22nd. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $4.58.

Hyperion DeFi Trading Down 3.7%

NASDAQ HYPD opened at $3.37 on Monday. The stock has a market cap of $27.54 million, a PE ratio of -0.83 and a beta of 2.80. Hyperion DeFi has a 12 month low of $0.85 and a 12 month high of $17.99. The company’s 50-day moving average price is $4.79 and its 200-day moving average price is $7.60. The company has a current ratio of 2.25, a quick ratio of 2.25 and a debt-to-equity ratio of 0.11.

Hyperion DeFi (NASDAQ:HYPD) last released its quarterly earnings data on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. The company had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative net margin of 62,238.41% and a negative return on equity of 119.59%. Equities research analysts forecast that Hyperion DeFi will post -41.6 earnings per share for the current year.

Insider Buying and Selling at Hyperion DeFi

In related news, Director Happy David Walters purchased 61,930 shares of the business’s stock in a transaction dated Wednesday, December 17th. The shares were acquired at an average cost of $3.02 per share, for a total transaction of $187,028.60. Following the acquisition, the director owned 111,930 shares of the company’s stock, valued at $338,028.60. The trade was a 123.86% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael S. Geltzeiler purchased 30,000 shares of Hyperion DeFi stock in a transaction dated Wednesday, December 17th. The stock was bought at an average cost of $3.01 per share, with a total value of $90,300.00. Following the completion of the transaction, the director owned 88,015 shares in the company, valued at approximately $264,925.15. This represents a 51.71% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last 90 days, insiders have purchased 161,254 shares of company stock valued at $511,126. 10.86% of the stock is currently owned by corporate insiders.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.